Apogee Therapeutics, Inc. Marketable Securities (Current)
Apogee Therapeutics, Inc. (APGE) had Marketable Securities (Current) of $866.36 million as of 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments
us-gaap:MarketableSecuritiesCurrent · last filed 2026-08-10
- 2026-06-30: Marketable Securities, Current $866.36M.
- 2026-03-31: Marketable Securities, Current $608.09M.
- 2025-12-31: Marketable Securities, Current $598.64M.
- 2025-09-30: Marketable Securities, Current $419.38M.
| Period end | Marketable Securities, Current |
|---|---|
| 2026-06-30 | $866.36M 10-Q · filed 2026-08-10 |
| 2026-03-31 | $608.09M 10-Q · filed 2026-05-11 |
| 2025-12-31 | $598.64M 10-Q · filed 2026-08-10 |
| 2025-09-30 | $419.38M 10-Q · filed 2025-11-10 |
| 2025-06-30 | $381.23M 10-Q · filed 2025-08-11 |
| 2025-03-31 | $406.41M 10-Q · filed 2025-05-12 |
| 2024-12-31 | $378.86M 10-K · filed 2026-03-02 |
| 2024-09-30 | $407.27M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $368.93M 10-Q · filed 2024-08-12 |
| 2024-03-31 | $330.74M 10-Q · filed 2024-05-13 |
| 2023-12-31 | $277.14M 10-K · filed 2025-03-03 |
| 2023-09-30 | $234.59M 10-Q · filed 2023-11-13 |